title: Expression of deltaNp63 in squamous cell carcinoma of the esophagus.
abstract: BACKGROUND
  The p63 gene is present as two isoforms, namely TAp63 and deltaNp63. The biological role of deltaNp63 in the progression of esophageal cancer is still controversial.
  
  
  METHODS
  The expression of deltaNp63, as well as that of p63, was immunohistochemically examined in 61 resected specimens of squamous cell carcinoma of the esophagus.
  
  
  RESULTS
  The incidences of a positive deltaNp63 expression were 32 and 64% in carcinomas with and without adventitial invasion, respectively, and 37 and 65% in those with and without lymph node metastasis, respectively (p<0.05). The prognosis was significantly better in the positive deltaNp63 group than in the negative group (p<0.01). However, a multivariate analysis revealed deltaNp63 not to be an independent prognostic factor. Regarding p63, diminished expression was more frequently observed in advanced carcinomas, however, there were no statistically significant differences.
  
  
  CONCLUSIONS
  The impaired deltaNp63 reflects the progression of squamous cell carcinoma of the esophagus.
authors.affiliation: Second Department of Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, 807-8555, Japan. m-morita@med.uoeh-u.ac.jp
authors.forename: Masaru
authors.initials: M
authors.lastname: Morita
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Uramoto
authors.forename: Shoji
authors.initials: S
authors.lastname: Nakata
authors.forename: Kenji
authors.initials: K
authors.lastname: Ono
authors.forename: Masakazu
authors.initials: M
authors.lastname: Sugaya
authors.forename: Takashi
authors.initials: T
authors.lastname: Yoshimatsu
authors.forename: Tsunehiro
authors.initials: T
authors.lastname: Oyama
authors.forename: Takeshi
authors.initials: T
authors.lastname: Hanagiri
authors.forename: Kenji
authors.initials: K
authors.lastname: Sugio
authors.forename: Kosei
authors.initials: K
authors.lastname: Yasumoto
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D004268:DNA-Binding Proteins; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D005260:Female; D015870:Gene Expression; D016147:Genes, Tumor Suppressor; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D010750:Phosphoproteins / Q000096:biosynthesis* / Q000235:genetics; D011379:Prognosis; D015534:Trans-Activators / Q000096:biosynthesis* / Q000235:genetics; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins
chemical_list: D004268:DNA-Binding Proteins; D010750:Phosphoproteins; C115051:TP63 protein, human; D015534:Trans-Activators; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins